1. Home
  2. PEN vs ARCC Comparison

PEN vs ARCC Comparison

Compare PEN & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$318.39

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$18.69

Market Cap

13.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEN
ARCC
Founded
2004
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
13.6B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
PEN
ARCC
Price
$318.39
$18.69
Analyst Decision
Hold
Buy
Analyst Count
16
11
Target Price
$360.14
$21.36
AVG Volume (30 Days)
362.8K
5.3M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
10.28%
EPS Growth
1155.56
N/A
EPS
0.82
0.13
Revenue
$1,403,665,000.00
N/A
Revenue This Year
$14.34
$5.77
Revenue Next Year
$13.71
$2.29
P/E Ratio
$388.48
$143.81
Revenue Growth
17.50
N/A
52 Week Low
$221.26
$17.40
52 Week High
$362.41
$23.42

Technical Indicators

Market Signals
Indicator
PEN
ARCC
Relative Strength Index (RSI) 48.53 54.96
Support Level $317.81 $18.40
Resistance Level $322.24 $19.36
Average True Range (ATR) 2.40 0.31
MACD 0.29 0.05
Stochastic Oscillator 53.86 64.80

Price Performance

Historical Comparison
PEN
ARCC

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

Share on Social Networks: